Abstract | OBJECTIVES: PATIENTS AND METHODS: In this study, we related plasma cerebrosterol concentrations in 46 MS patients - 27 with a relapsing-remitting (RR) disease course and 19 with a primary progressive (PP) course - to three conventional magnetic resonance imaging measures: on T(1)-weighted brain scans, volume of gadolinium-enhanced lesions (a marker of active inflammation) and hypointense lesions (a marker of edema or axonal loss) and on T(2)-weighted scans, volume of hyperintense lesions (a marker of disease extent). RESULTS: By multiple-regression analysis, we uncovered negative correlations between the cerebrosterol- cholesterol ratio in plasma and both age at sampling (beta=-0.35 and p=0.079 in RRMS; beta=-0.76 and p=0.006 in PPMS) and volume of T(2)-weighted lesions (beta=-0.52 and p=0.078 in RRMS; beta=-0.50 and p=0.247 in PPMS). CONCLUSION: We hypothesize that decreases in plasma cerebrosterol may reflect the total spatiotemporal burden of MS-the cumulative effects of its dissemination in space and its duration in time.
|
Authors | Virginija Danylaité Karrenbauer, Valerio Leoni, Ee Tuan Lim, Gavin Giovannoni, Gordon T Ingle, Jaume Sastre-Garriga, Alan J Thompson, Waqar Rashid, Gerard Davies, David H Miller, Ingemar Björkhem, Thomas Masterman |
Journal | Clinical neurology and neurosurgery
(Clin Neurol Neurosurg)
Vol. 108
Issue 5
Pg. 456-60
(Jul 2006)
ISSN: 0303-8467 [Print] Netherlands |
PMID | 16144738
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Hydroxycholesterols
- 24-hydroxycholesterol
- Cholesterol
|
Topics |
- Adult
- Brain
(metabolism, pathology)
- Cholesterol
(blood)
- Female
- Humans
- Hydroxycholesterols
(blood)
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting
(blood, pathology)
- Plasma
- Sampling Studies
|